Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 12 de 12
Filtrar
1.
Clin Exp Dermatol ; 44(3): 270-276, 2019 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29974485

RESUMO

BACKGROUND: There are few studies in the literature correlating the ultrasonographic findings, clinical scoring systems or histological findings in morphoea after ultraviolet (UV)A1 phototherapy. AIMS: To evaluate the quantitative and morphological aspects of high-frequency ultrasonography in the treatment of plaque morphoea in response to UVA1 phototherapy, and to correlate these with clinical and histological scores. METHODS: In total, 17 patients with morphoea were studied. Initially and at study end, high-frequency ultrasonography (50 MHz) was performed on the edge of a morphoea lesion treated with UVA1 phototherapy. A quantitative and qualitative analysis of dermal features was performed and compared with the features of healthy skin. Skin biopsy specimens were obtained from lesions analysed at the beginning and end of the study, assessing dermal sclerosis and dermal inflammatory infiltrate and their distribution. RESULTS: All affected skin showed a statistically significant increase in dermal thickness and hypoechogenicity, corresponding to a reduction in dermal density by ultrasonography compared with healthy skin. Morphological evaluation identified undulations of the dermis in 11 of 17 lesions (64.7%) and in 5 healthy skin areas (29.4%) (P = 0.08), while 'yoyo' figures were identified in 8 lesions (47%) but only 1 healthy skin area (5.9%) (P = 0.02). Ultrasonographic morphological analysis highlighted an improvement in dermal hyperechogenic bands and disappearance of yoyo figures after UVA1 treatment. Histology revealed a reduction in dermal sclerosis and inflammation, although this was not statistically significant. CONCLUSIONS: Ultrasonographic pattern analysis of morphoea is a suitable technique for monitoring UVA1 phototherapy response.


Assuntos
Esclerodermia Localizada/diagnóstico por imagem , Esclerodermia Localizada/radioterapia , Terapia Ultravioleta/métodos , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Esclerodermia Localizada/patologia , Resultado do Tratamento , Adulto Jovem
2.
Clin Genet ; 92(6): 624-631, 2017 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-28485813

RESUMO

Classical Ehlers-Danlos syndrome (cEDS) is characterized by marked cutaneous involvement, according to the Villefranche nosology and its 2017 revision. However, the diagnostic flow-chart that prompts molecular testing is still based on experts' opinion rather than systematic published data. Here we report on 62 molecularly characterized cEDS patients with focus on skin, mucosal, facial, and articular manifestations. The major and minor Villefranche criteria, additional 11 mucocutaneous signs and 15 facial dysmorphic traits were ascertained and feature rates compared by sex and age. In our cohort, we did not observe any mandatory clinical sign. Skin hyperextensibility plus atrophic scars was the most frequent combination, whereas generalized joint hypermobility according to the Beighton score decreased with age. Skin was more commonly hyperextensible on elbows, neck, and knees. The sites more frequently affected by abnormal atrophic scarring were knees, face (especially forehead), pretibial area, and elbows. Facial dysmorphism commonly affected midface/orbital areas with epicanthal folds and infraorbital creases more commonly observed in young patients. Our findings suggest that the combination of ≥1 eye dysmorphism and facial/forehead scars may support the diagnosis in children. Minor acquired traits, such as molluscoid pseudotumors, subcutaneous spheroids, and signs of premature skin aging are equally useful in adults.


Assuntos
Colágeno Tipo V/genética , Síndrome de Ehlers-Danlos/genética , Anormalidades do Olho/genética , Instabilidade Articular/genética , Anormalidades da Pele/genética , Adolescente , Adulto , Criança , Pré-Escolar , Estudos de Coortes , Colágeno Tipo V/metabolismo , Síndrome de Ehlers-Danlos/diagnóstico , Síndrome de Ehlers-Danlos/metabolismo , Síndrome de Ehlers-Danlos/patologia , Anormalidades do Olho/diagnóstico , Anormalidades do Olho/metabolismo , Anormalidades do Olho/patologia , Face/anormalidades , Feminino , Expressão Gênica , Humanos , Instabilidade Articular/diagnóstico , Instabilidade Articular/metabolismo , Instabilidade Articular/patologia , Articulações/anormalidades , Articulações/metabolismo , Masculino , Pessoa de Meia-Idade , Mutação , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismo , Anormalidades da Pele/diagnóstico , Anormalidades da Pele/metabolismo , Anormalidades da Pele/patologia
3.
Br J Dermatol ; 174(2): 380-5, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26498991

RESUMO

BACKGROUND: Surgical excision represents the most common elective treatment for basal cell carcinoma (BCC). Several noninvasive approaches have been proposed for in vivo determination of tumour margin, in order to achieve radical removal. OBJECTIVES: To propose a new approach through the combination of dermoscopy and reflectance confocal microscopy (RCM) for lateral margin detection in BCC. METHODS: Ten patients with lesions clinically suggestive of nonpigmented BCCs with ill-defined margins were enrolled. All BCCs were dermoscopically evaluated first and the ill-defined margins were marked with a superficial cut and then inspected using RCM. RESULTS: RCM evaluation showed BCC foci beyond the presurgical marker in three out of 10 lesions. Histology confirmed the RCM results: the presence of BCC features across the cut, corresponding to two superficial BCCs and a morpheaform BCC. CONCLUSIONS: This new procedure helped to improve the identification of proper margins for surgical excision in nonpigmented BCC with clinically and dermoscopically ill-defined margins.


Assuntos
Carcinoma Basocelular/cirurgia , Neoplasias Cutâneas/cirurgia , Adulto , Idoso , Idoso de 80 Anos ou mais , Carcinoma Basocelular/diagnóstico por imagem , Carcinoma Basocelular/patologia , Dermoscopia/métodos , Feminino , Humanos , Masculino , Margens de Excisão , Microscopia Confocal/métodos , Pessoa de Meia-Idade , Cuidados Pré-Operatórios/métodos , Neoplasias Cutâneas/diagnóstico por imagem , Neoplasias Cutâneas/patologia
5.
Pharmacol Toxicol ; 88(2): 67-74, 2001 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-11169164

RESUMO

The antiviral and antiproliferative activity of new compounds having n-benzenesulphony 1-2 (2 or 3-pyridylethyl) benzimidazole as a base structure were studied in vitro. Their antitumour activity against human chronic myeloid leukaemia cells was evaluated and compared with that of equimolar doses of daunorubicin. Only compound 7a, with the presence of both the pyridyl moiety bound at the ethylenic bridge in C-2 of benzimidazole and the nitro-group in the benzene ring, displays a selective antiproliferative effect against certain leukaemia cells and a good antiviral activity especially towards the Coxsackie B5 virus. However, it should be noted that, in the case of hydroxybenzyl-benzimidazole, resistance also builds up to compound 7a, the Coxsackie B5 virus developing resistance to it after about ten runs. Cytotoxicity tests show that many of these substances are well tolerated by the VERO cells. The mechanism of action is still unclear.


Assuntos
Antineoplásicos/farmacologia , Antivirais/farmacologia , Benzimidazóis/farmacologia , Células Tumorais Cultivadas/efeitos dos fármacos , Vírus/efeitos dos fármacos , Animais , Linfoma de Burkitt/tratamento farmacológico , Linfoma de Burkitt/patologia , Divisão Celular/efeitos dos fármacos , Chlorocebus aethiops , Daunorrubicina/farmacologia , Relação Dose-Resposta a Droga , Resistência Microbiana a Medicamentos , Enterovirus Humano B/efeitos dos fármacos , Humanos , Leucemia Mielogênica Crônica BCR-ABL Positiva/tratamento farmacológico , Leucemia Mielogênica Crônica BCR-ABL Positiva/patologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/tratamento farmacológico , Leucemia-Linfoma Linfoblástico de Células Precursoras/patologia , Células Vero/efeitos dos fármacos
6.
Anesth Analg ; 89(4): 1050-5, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10512289

RESUMO

UNLABELLED: We investigated the changes in oxidative stress in platelets from surgical patients anesthetized with propofol. We studied 60 surgical patients (ASA physical status I and II) and 12 healthy volunteers. The patients were divided into three groups: anesthesia induced with an IV bolus dose of 4 mg/kg thiopental; anesthesia induced with an IV bolus dose of 2 mg/kg propofol; and total IV anesthesia (induction with propofol 2 mg/kg, infusion with propofol 10 mg/kg during the first 10 min, then 8 mg/kg for 10 min, and 6 mg/kg during the rest of the operation). Healthy volunteers were given an IV bolus dose of 10% fat emulsion (Intralipid). We measured the following variables in platelets: thiobarbituric acid reactive substances content, glutathione content, and glutathione peroxidase, reductase, and transferase activities. Thiopental did not modify any of the variables. Propofol decreased thiobarbituric acid reactive substances production by 25.7% and increased total glutathione content by 24.6%. The percentage of glutathione in oxidized form was 29.5% smaller in patients anesthetized with propofol. Glutathione peroxidase activity was 28.3% less, glutathione transferase was 44.5% more, and glutathione reductase was not significantly different. Intralipid had no effect on any of the variables. After infusion of propofol for 1 h, the effects were, in qualitative terms, the same as those seen after an initial bolus dose. In conclusion, our findings show that propofol has an antioxidant effect in humans. This effect may be beneficial in patients who have diseases in which free radicals play an important role. IMPLICATIONS: This study demonstrates that propofol inhibits cellular oxidative damage, measured in platelets from surgical patients. Neither thiopental nor the fat emulsion (Intralipid) showed any effect. Moreover, propofol increased the antioxidant defense of glutathione. This could be applied in the protection of tissues from ischemic damage.


Assuntos
Anestésicos Intravenosos/administração & dosagem , Plaquetas/efeitos dos fármacos , Sequestradores de Radicais Livres/administração & dosagem , Estresse Oxidativo/efeitos dos fármacos , Propofol/administração & dosagem , Procedimentos Cirúrgicos Operatórios , Adulto , Anestésicos Intravenosos/farmacologia , Antioxidantes/administração & dosagem , Antioxidantes/farmacologia , Plaquetas/enzimologia , Plaquetas/metabolismo , Emulsões Gordurosas Intravenosas/uso terapêutico , Feminino , Sequestradores de Radicais Livres/farmacologia , Glutationa/análise , Glutationa Peroxidase/análise , Glutationa Redutase/análise , Glutationa Transferase/análise , Humanos , Masculino , Propofol/farmacologia , Substâncias Reativas com Ácido Tiobarbitúrico/análise , Tiopental/administração & dosagem
7.
J Am Acad Dermatol ; 37(5 Pt 2): 884-6, 1997 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-9366859

RESUMO

Reticulate acropigmentation (RA) comprises dyschromic disorders that generally have an autosomal dominant pattern of inheritance, Two main forms of RA have been described: reticulate acropigmentation of Kitamura (RAK) and reticulate acropigmentation of Dohi (RAD). We observed a 21-year-old white woman who had progressive reticulate hyper- and hypopigmentation on the volar surface of her forearms and the dorsa of her hands. Many of her relatives have similar lesions. There were no pits or breaks in the epidermal ridge pattern on the palms. A biopsy specimen revealed areas with an excess of melanin in the basal layer alternating with others in which melanin was totally absent, Electron microscopic findings in a hypermelanotic area showed an increased number of melanocytes with high metabolic activity. In the hypomelanotic areas the melanocytes were morphologically abnormal with melanosomes at the early stages of development.


Assuntos
Transtornos da Pigmentação/genética , Pele/patologia , Adulto , Biópsia , Feminino , Antebraço , Mãos , Humanos , Melaninas/análise , Melanócitos/ultraestrutura , Linhagem , Pele/química , Pigmentação da Pele
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA